A Study of LTZ-301 in People With Non-Hodgkin Lymphoma

Full Title

A Phase 1 Open-label, Multicenter Study of LTZ-301 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Pallawi Torka’s office at 201-775-7808.

Protocol
26-182
Phase
Phase I (phase 1)
Disease Status
Relapsed or Refractory
Investigator
Pallawi Torka
Co-Investigators
Gilles Salles
Diseases
Lymphoma › Non-Hodgkin's Lymphoma
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07121946
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description